Eravac
Active substance
ATC code
Species
Rabbits
Indications
For active immunisation of rabbits from the age of 30 days to reduce mortality caused by the rabbit haemorrhagic disease type 2 virus (RHDV2).
Onset of immunity: 1 week.
Duration of immunity: 12 months demonstrated by challenge
Dose to be administered and administration route
Subcutaneous use.
Administer 1 dose (0.5 ml) of the vaccine to rabbits from the age of 30 days by subcutaneous injection in the lateral thoracic wall.
Revaccination: every 12 months after the last vaccination.
Before use allow the vaccine to reach room temperature.
Shake well before administration.
Adverse reactions
A transient temperature increase slightly above 40 ºC between two or three days following vaccination was observed very commonly during safety studies. This slight temperature increase resolves spontaneously without treatment by day 5 post vaccination.
Nodules or swellings (< 2 cm) at the injection site were observed very commonly during safety studies. These local reactions may last 24 hours and gradually reduce and disappear without need for treatment.
Lethargy and/or inappetence in the first 48 hours after injection may be observed very rarely , based on post-authorisation pharmacovigilance reporting.
The frequency of adverse reactions is defined using the following convention:
-very common (more than 1 in 10 animals treated displaying adverse reaction (s)
-common (more than 1 but less than 10 animals in 100 animals treated)
-uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
-rare (more than 1 but less than 10 animals in 10,000 animals treated)
-very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
